B-cell involvement in chronic graft-versus-host disease

Haematologica
Rick KapurAnton Hagenbeek

Abstract

Chronic graft-versus-host disease is a serious complication in long-term survivors of allogeneic hematopoietic stem cell transplantation, with several organ systems affected. Chronic graft-versus-host disease is an important cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation. This article reviews the pathogenesis of chronic graft-versus-host disease. In particularly, the role of B cells in chronic graft-versus-host disease is evaluated, as is evident from several studies which have investigated the presence of antibodies as well as studies which have analyzed B cells as a target for immunotherapy. Thirty autoantibodies and 5 alloantibodies have been identified in chronic graft-versus-host disease patients in 24 studies, and 8 autoantibodies and 5 alloantibodies seemed to be strongly associated with chronic graft-versus-host disease. In addition, various studies have observed significant improvements in chronic graft-versus-host disease using the anti-CD20(+) antibody rituximab. However, it appears to be highly likely that both B cells as well as T cells are of major importance in chronic graft-versus-host disease. Further research is required to clarify the pathogenesis of chronic graft-versu...Continue Reading

Citations

May 7, 2011·International Journal of Hematology·Mohamed A Kharfan-Dabaja, Corey S Cutler
Aug 18, 2009·Bone Marrow Transplantation·D PulanicS Z Pavletic
Aug 7, 2012·Bone Marrow Transplantation·C J RodgersA Peniket
May 13, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Isabel VoglerManuel Grez
Nov 30, 2011·TheScientificWorldJournal·Jacopo OlivieriAttilio Olivieri
May 31, 2014·Transplantation·Andrada ChironDjaouida Bengoufa
Sep 9, 2009·British Journal of Haematology·Olle RingdénMichael Uhlin
Aug 18, 2009·Cancer Treatment Reviews·Voravit RatanatharathornJoseph P Uberti
Apr 13, 2015·International Journal of Hematology·Muhammad Omer Jamil, Shin Mineishi
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Bruce BlazarDaniel Couriel
Jun 11, 2014·Blood·Gérard Socié, Jerome Ritz
Jul 6, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Vanessa E KennedyMadan Jagasia
Apr 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katayoun Rezvani, Richard E Champlin
Jan 30, 2018·Frontiers in Immunology·Ahmad KhoderKatayoun Rezvani
Jan 11, 2018·Therapeutic Advances in Hematology·LaQuisa HillElizabeth Shpall
Feb 6, 2009·The Annals of Pharmacotherapy·Jill S BatesJulia M Hammond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Stamatis-Nick C Liossis, Petros P Sfikakis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Stefanie SarantopoulosJerome Ritz
Pediatric Clinics of North America
Kristin BairdKirk R Schultz
© 2022 Meta ULC. All rights reserved